In our cohort of CKD patients, we observed that circulating proinflammatory CD14++CD16+ monocytes showed upregulated expression of IL1β in 22% of patients with CAD, which might also contribute to the endothelial damage and promote accelerated ATH and increased CVD risk. Here, IL1B is linked to chronic kidney disease.